Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment ...

TD Cowen 45th Annual Health Care Conference, March 3-5, 2025 Event details: Date: Monday, March 3, 2025 Time: 2:30 pm ET Location: Boston, MA Participants may access a live webcast of the event by ...

The webcast may also be accessed through Spero Therapeutics’ website (www.sperotherapeutics.com) on the “Events and Presentations” page under the “Connect” tab. A replay will be available on the ...

A live webcast can be accessed under "Events & Presentations” in the Investors & Media section of the Xilio Therapeutics ...

Outset Medical, Inc. (Nasdaq: OM) ("Outset”), a medical technology company pioneering a first-of-its-kind technology to ...

Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood ...

today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m. ET. Live and replay webcasts may be accessed in ...

Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will participate in a fireside chat presentation at the 45th Annual TD Cowen Health Care Conference on ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the TD ...

(NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a ...

MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management ...